These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3365303)

  • 1. The development of sparsomycin as an anti-tumour drug.
    Ottenheijm HC; van den Broek LA
    Anticancer Drug Des; 1988 Mar; 2(4):333-7. PubMed ID: 3365303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of sparsomycin analogues.
    Duke SS; Boots MR
    J Med Chem; 1983 Nov; 26(11):1556-61. PubMed ID: 6415284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparsomycin analogs. II. Synthesis and biological activities of 5-carboxy-6-methyluracil derivatives.
    Kanatomo S; Nagai S; Hase T; Ohki K; Nomura C; Okezaki E
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):135-43. PubMed ID: 6850930
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth.
    van den Broek LA; Liskamp RM; Colstee JH; Lelieveld P; Remacha M; Vázquez D; Ballesta JP; Ottenheijm HC
    J Med Chem; 1987 Feb; 30(2):325-33. PubMed ID: 3543365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.
    van den Broek LA; Lázaro E; Zylicz Z; Fennis PJ; Missler FA; Lelieveld P; Garzotto M; Wagener DJ; Ballesta JP; Ottenheijm HC
    J Med Chem; 1989 Aug; 32(8):2002-15. PubMed ID: 2754719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chiral synthesis and biochemical properties of electron rich phenolic sulfoxide analogs of sparsomycin.
    Flynn GA; Ash RJ
    Biochem Biophys Res Commun; 1990 Jan; 166(2):673-80. PubMed ID: 2405852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparsomycin analogs. VI. Synthesis and antitumor activity of octylsparsomycin analogs.
    Kanatomo S; Hase T; Wada A; Ohki K; Nagai S; Tanaka M; Sasaki T
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):688-91. PubMed ID: 2752478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesis.
    Zylicz Z; Wagener DJ; van Rennes H; Wessels JM; van der Kleijn E; de Grip WJ; van den Broek LA; Ottenheijm HC
    J Natl Cancer Inst; 1987 Apr; 78(4):701-5. PubMed ID: 3470545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and morphological reversion activity on srctsNRK cells of pyrimidinylpropanamide antibiotics, sparsomycin, sparoxomycin A1, A2, and their analogues.
    Nakajima N; Enomoto T; Matsuura N; Ubukata M
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3331-4. PubMed ID: 9873729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein biosynthesis: the first active sparsomycin analog.
    Vince R; Brownell J; Lee CK
    Biochem Biophys Res Commun; 1977 Apr; 75(3):563-7. PubMed ID: 856177
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and activity of pyrimidinylpropenamide antibiotics: the alkyl analogues of sparsomycin.
    Nakajima N; Enomoto T; Watanabe T; Matsuura N; Ubukata M
    Biosci Biotechnol Biochem; 2003 Dec; 67(12):2556-66. PubMed ID: 14730133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidinylpropenamides as antitumor agents. Analogues of the antibiotic sparsomycin.
    Lin CC; Dubois RJ
    J Med Chem; 1977 Mar; 20(3):337-41. PubMed ID: 845865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparsomycin analogs. V. Synthesis and antitumor activity of (E)-beta-(pyrimidin-5-yl)acrylamides.
    Kanatomo S; Wada A; Hamaoka Y; Nagai S; Fukuda S; Tanaka M; Sasaki T
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4421-5. PubMed ID: 3246010
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical pharmacokinetics of the antitumor antibiotic deshydroxy-sparsomycin in beagle dogs.
    Zylicz Z; Wagener DJ; Garzotto M; Vree TB; van der Kleijn E; van den Broek LA; Ottenheijm HC
    Anticancer Res; 1988; 8(6):1381-5. PubMed ID: 3218972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycin.
    Zylicz Z; Hofs HP; Wagener DJ; Van Rennes H; Wessels JM; van den Broek LA; Ottenheijm HC
    Anticancer Res; 1989; 9(6):1835-40. PubMed ID: 2483308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necessity of the sulfoxide moiety for the biochemical and biological properties of an analog of sparsomycin.
    Flynn GA; Ash RJ
    Biochem Biophys Res Commun; 1983 Jul; 114(1):1-7. PubMed ID: 6349625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sparsomycin analogues on the puromycin-peptidyl transferase reaction on ribosomes.
    Lee CK; Vince R
    J Med Chem; 1978 Feb; 21(2):176-9. PubMed ID: 340693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and biological aspects of sparsomycin, an antibiotic from Streptomyces.
    Ottenheijm HC; van den Broek LA; Ballesta JP; Zylicz Z
    Prog Med Chem; 1986; 23():219-68. PubMed ID: 3310108
    [No Abstract]   [Full Text] [Related]  

  • 19. Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
    Kallia-Raftopoulos S; Synetos D; Ottenheijm HC; van den Broek LA; Coutsogeorgopoulos C
    Mol Pharmacol; 1996 Jun; 49(6):1085-91. PubMed ID: 8649347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of sparsomycin: modification at the hydroxyl group.
    Lázaro E; van den Broek LA; Ottenheijm HC; Lelieveld P; Ballesta JP
    Biochimie; 1987 Aug; 69(8):849-56. PubMed ID: 3122847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.